Biodesy is developing the first products and systems to rapidly and inexpensively measure both protein structure and function in real time, with applications including drug discovery, structural biology and clinical biomarkers. Biodesy has developed a unique and highly sensitive technology for detecting conformational change in proteins and other biological molecules. Our technology, based on a phenomenon called second-harmonic generation, can monitor structural changes at any site within a protein, in real time. Since protein function is determined by its structure, and changes in structure cause changes in function, characterizing these changes will provide significant insights into how our bodies function and respond to treatments.


Biodesy Delta System Enables Researchers to Discover Novel Mechanism Involved in Infectious Disease

November 20, 2017

Biodesy Appoints Dominique Bridon as Chief Executive Officer

June 29, 2017


The New York Academy of Sciences: Thinking Outside the ATP Box: New Ways to Target Kinases for Therapeutics

May 22-22, 2018 The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York

Drug Discovery Chemistry 2018

April 2-6, 2018 San Diego, CA